The impact of fibrinolytic therapy for ST-segment-elevation acute myocardial infarction. | J Thromb Haemost;7(1): 14-20, 2009 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

The impact of fibrinolytic therapy for ST-segment-elevation acute myocardial infarction.

Van de Werf, F J; Topol, E J; Sobel, B E.

Affiliation

Van de Werf FJ; Department of Cardiology, University Hospitals Leuven, Leuven, Belgium. frans.vandewerf@uz.kuleuven.ac.be

J Thromb Haemost ; 7(1): 14-20, 2009 Jan.

Article in En | MEDLINE | ID: mdl-19090814

Subject(s)

Myocardial Infarction/drug therapy; Thrombolytic Therapy; Anticoagulants/therapeutic use; Fibrinolytic Agents/therapeutic use; History, 20th Century; History, 21st Century; Humans; Thrombolytic Therapy/history; Thrombolytic Therapy/trends; Tissue Plasminogen Activator/therapeutic use

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombolytic Therapy / Myocardial Infarction Limits: Humans Language: En Journal: J Thromb Haemost Year: 2009 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombolytic Therapy / Myocardial Infarction Limits: Humans Language: En Journal: J Thromb Haemost Year: 2009 Document type: Article